19, 2015 – – New gene variants linked to the epidermis condition eczema have already been identified by a global team of researchers. Eczema, characterized by itchy, red rashes, is known to run in families. The new findings enhance the true quantity of genetic variants known to increase risk for the problem, making the full total 31. The researchers did this by analyzing the genomes of 377,000 people worldwide. Though the genetic variants identified in this current study represent only a little proportion of the chance for developing eczema.The remaining 124 patients didn’t receive consolidation therapy after cycle 2. In the intermediate-dose group, 170 patients had a relapse and 260 died, including 31 while these were in the first complete remission. In the high-dose group, 157 patients had a relapse and 251 died, including 46 through the first complete remission. At 5 years, there were no significant differences between your intermediate-dose group and the high-dose group in the price of event-free survival or overall survival . The cumulative 5-yr probabilities for the competing risks of failure after complete remission were also very similar in these two groups: 39 percent and 37 percent, respectively, for relapse and 7 percent and 11 percent for death through the first total remission.